|
1
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I: EUROCARE-4 Working
Group: Recent cancer survival in Europe: A 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang
Y, Ye S, Wu S, Zhong G, Ren J, et al: MicroRNA-143 inhibits
migration and invasion of human non-small-cell lung cancer and its
relative mechanism. Int J Biol Sci. 9:680–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y, Li M, Zhang G and Pang Z:
MicroRNA-10b overexpression promotes non-small cell lung cancer
cell proliferation and invasion. Eur J Med Res. 18:412013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chi SW, Zang JB, Mele A and Darnell RB:
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature.
460:479–486. 2009.PubMed/NCBI
|
|
7
|
Hale BJ, Yang CX and Ross JW: Small RNA
regulation of reproductive function. Mol Reprod Dev. 81:148–159.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding J, Huang S, Wu S, Zhao Y, Liang L,
Yan M, Ge C, Yao J, Chen T, Wan D, et al: Gain of miR-151 on
chromosome 8q24.3 facilitates tumour cell migration and spreading
through downregulating RhoGDIA. Nat Cell Biol. 12:390–399. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma L, Reinhardt F, Pan E, Soutschek J,
Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW and Weinberg RA:
Therapeutic silencing of mir-10b inhibits metastasis in a mouse
mammary tumor model. Nat Biotechnol. 28:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho WC: MicroRNAs: Potential biomarkers
for cancer diagnosis, prognosis and targets for therapy. Int J
Biochem Cell Biol. 42:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cho WC: MicroRNAs in cancer-from research
to therapy. Biochim Biophys Acta. 1805:209–217. 2010.PubMed/NCBI
|
|
16
|
Gabriely G, Teplyuk NM and Krichevsky AM:
Context effect: microRNA-10b in cancer cell proliferation, spread
and death. Autophagy. 7:1384–1386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Jiang Q, Xia N, Yang H and Hu C:
Decreased expression of microRNA-375 in nonsmall cell lung cancer
and its clinical significance. J Int Med Res. 40:1662–1669. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y and Lee CG: MicroRNA and
cancer-focus on apoptosis. J Cell Mol Med. 13:12–23. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Avnit-Sagi T, Kantorovich L, Kredo-Russo
S, Hornstein E and Walker MD: The promoter of the pri-miR-375 gene
directs expression selectively to the endocrine pancreas. PLoS One.
4:e50332009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu AM, Poon RT and Luk JM: MicroRNA-375
targets Hippo-signaling effector YAP in liver cancer and inhibits
tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poy MN, Hausser J, Trajkovski M, Braun M,
Collins S, Rorsman P, Zavolan M and Stoffel M: miR-375 maintains
normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci
USA. 106:5813–5818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kloosterman WP, Lagendijk AK, Ketting RF,
Moulton JD and Plasterk RH: Targeted inhibition of miRNA maturation
with morpholinos reveals a role for miR-375 in pancreatic islet
development. PLoS Biol. 5:e2032007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen ZY, Zhang ZZ, Liu H, Zhao EH and Cao
H: miR-375 inhibits the proliferation of gastric cancer cells by
repressing ERBB2 expression. Exp Ther Med. 7:1757–1761.
2014.PubMed/NCBI
|
|
26
|
Zhang ZW, Men T, Feng RC, Li YC, Zhou D
and Teng CB: miR-375 inhibits proliferation of mouse pancreatic
progenitor cells by targeting YAP1. Cell Physiol Biochem.
32:1808–1817. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitri Z, Constantine T and O'Regan R: The
HER2 receptor in breast cancer: Pathophysiology, clinical use and
new advances in therapy. Chemother Res Pract.
2012:7431932012.PubMed/NCBI
|
